Rani Therapeutics Holdings Inc - Class A — Cash Flow (NASDAQ:RANI)

Financials

Cash from operating activities 32.2 M46.5 M51.2 M35.5 M 27.66 M Cash from investing activities 506 K72.44 M29.86 M19.81 M 26.46 M Cash from financing activities 77.15 M29 M233 K13.59 M 10.17 M Free cash flow 31.69 M44.88 M49.97 M35.23 M 27.54 M

新闻

Rani Therapeutics任命Alireza Javadi为首席技术官

Rani Therapeutics promotes Alireza Javadi to chief technical officer

Rani Therapeutics begins phase 1 trial of oral obesity treatment

Rani Therapeutics修改公司章程，降低B类股投票权并终止税务协议

Rani Therapeutics amends charter, reduces Class B voting power and ends tax agreement

Rani Therapeutics宣布与中外制药达成价值10.85亿美元合作协议

Rani Therapeutics announces $1.085 billion Chugai collaboration

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.09%

美国股市上涨；截至收盘道琼斯工业平均指数上涨0.09%

Monday’s Insider Moves: Top Buys and Sells in US Stocks on October 27

Rani Therapeutics董事Imran Mir A购入价值126万美元股票

Rani Therapeutics director Imran Mir a buys $1.26 million in stock